SignatureFD’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.3K Sell
2,029
-209
-9% -$1.97K ﹤0.01% 2293
2026
Q1
$18.2K Buy
2,238
+1,147
+105% +$9.85K ﹤0.01% 2238
2025
Q4
$11.3K Hold
1,091
﹤0.01% 2376
2025
Q3
$9.65K Sell
1,091
-993
-48% -$7.08K ﹤0.01% 2414
2025
Q2
$12K Buy
2,084
+738
+55% +$4.52K ﹤0.01% 2277
2025
Q1
$8.88K Sell
1,346
-783
-37% -$6.1K ﹤0.01% 2401
2024
Q4
$18.5K Buy
2,129
+43
+2% +$619 ﹤0.01% 2095
2024
Q3
$40.8K Sell
2,086
-3,192
-60% -$64.7K ﹤0.01% 1692
2024
Q2
$109K Buy
5,278
+253
+5% +$5.2K ﹤0.01% 1122
2024
Q1
$107K Sell
5,025
-13
-0.3% -$253 ﹤0.01% 1144
2023
Q4
$72.4K Buy
5,038
+1,449
+40% +$14.2K ﹤0.01% 1285
2023
Q3
$32.7K Buy
3,589
+172
+5% +$1.75K ﹤0.01% 1610
2023
Q2
$36.2K Buy
3,417
+164
+5% +$1.94K ﹤0.01% 1594
2023
Q1
$39.8K Buy
3,253
+322
+11% +$4.02K ﹤0.01% 1506
2022
Q4
$36.4K Buy
2,931
+11
+0.4% +$160 ﹤0.01% 1508
2022
Q3
$40K Buy
2,920
+33
+1% +$509 ﹤0.01% 1388
2022
Q2
$53K Sell
2,887
-160
-5% -$2.3K ﹤0.01% 1258
2022
Q1
$49K Buy
3,047
+122
+4% +$1.76K ﹤0.01% 1390
2021
Q4
$41K Buy
2,925
+38
+1% +$616 ﹤0.01% 1425
2021
Q3
$54K Hold
2,887
﹤0.01% 1265
2021
Q2
$60K Hold
2,887
﹤0.01% 1192
2021
Q1
$82K Hold
2,887
﹤0.01% 963
2020
Q4
$94K Buy
+2,887
New +$101K ﹤0.01% 813

Other funds holding KURA

SignatureFD's KURA Position: Q2 2026 in Review

SignatureFD reduced its Kura Oncology (KURA) stake by 9.3% in Q2 2026, selling an estimated $1.97K and leaving 2,029 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2293.

SignatureFD first reported a position in KURA in Q4 2020 and has held it in 23 quarters since. The position peaked at $109K in Q2 2024. 32 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • SignatureFD held 2,029 shares of Kura Oncology worth $22.3K as of Q2 2026.
  • SignatureFD sold 209 Kura Oncology shares in Q2 2026, an estimated $1.97K.
  • Kura Oncology made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2293 holding.
  • SignatureFD first reported a position in Kura Oncology in Q4 2020 and has held it in 23 quarters since.
  • SignatureFD's Kura Oncology position peaked at $109K in Q2 2024.
  • 32 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.